Acta Med. 2006, 49: 193-195
https://doi.org/10.14712/18059694.2017.131
Successful Treatment of Iron Overload with Phlebotomies in Two Siblings with Congenital Dyserythropoietic Anemia – Type II (CDA-II)
References
1. GM, Griffith PM, Nienhuis AW et al. Efficacy of deferoxamine in preventing complications of iron overload in patiens with thalassemia major. N Engl J Med 1994; 331:567–73.
<https://doi.org/10.1056/NEJM199409013310902>
2. A, Baiardi P, Filisi M. The safety and effectiveness of deferiprone in a large – scale, 3-year study in Italian patiens. Br J Haematol 2002; 118: 330–6.
<https://doi.org/10.1046/j.1365-2141.2002.03554.x>
3. L, Hůlek P, Nožička J. Kongenitální dyserythropoetická anémie – type II (CDA-II) u tří sourozenců s dlouhodobým sledováním a přetížením železem. Acta Medica (Hradec Králové) Suppl. 2004; 47 (1):29–33.
4. L, Matysová J. Excess of Pappenheimer bodies (siderocytes) in two splenectomized sibling with congenital dyserythropoietic anemia – type II (CDAII) and iron overload. Acta Medica (Hradec Králové) 2004; 47(3):187–8.
5. L, Špaček J. Příznivý vliv splenektomie na anémii u tří sourozenců s kongenitální dyserythropoietickou anémií – type II (HEMPAS) (ultrastrukturální změny erytrocytů po splenektomii). Vnitř Lék 1997; 43:635–8.
6. L, Radochová D, Smetana K et al. Congenital dyserytrhropoietic anaemia, type II (HEMPAS) in three siblings. Folia Haematol (Leipzig) 1980; 107: 628–40.
7. JH, Crookston MC, Burnie KL et al. Hereditary erythroblastic multinuclearity associated with a positive acidified – serum test: a type of congerital dyserythropoietic anemia. Br J Haematol 1969; 17:11–26.
<https://doi.org/10.1111/j.1365-2141.1969.tb05660.x>
8. R, Tiemann CD, Engelhardt R et al. Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Amer J Hematol 1999; 60:289–99.
<https://doi.org/10.1002/(SICI)1096-8652(199904)60:4<289::AID-AJH7>3.0.CO;2-W>
9. H, Anselstetter V, Chrobák L et al. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood 2003; 102:4576–81.
<https://doi.org/10.1182/blood-2003-02-0613>
10. WK, Kaltwasser JP, Hoelzer D et al. Successful treatment of iron overload by flebotomies in a patient with severe congenital dyserythropoietic anemia type II (letter). Blood 1997; 89:3068–9.
11. A, Roggero S, Longo F: Pathogenesis and management of iron – loading anemias. Hematology (EHA Educ. Program) 2006; 2:42–6.
12. W, Matthijs G, Roskams T, Fevery J. Noniatrogenic haemochromatosis in congenital dyserythropoietic anaemia type II is not related to C282Y and A63D mutations in the HFE gene: report on two brothers. Acta Clin Belg 2002; 57:79–84.
<https://doi.org/10.1179/acb.2002.018>
13. SN. Response of CDA type I to alpha – interferon. European J Haematology 1997; 58:121–3.
<https://doi.org/10.1111/j.1600-0609.1997.tb00935.x>
14. SN, Wood WG. Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol 2005; 131:431–46.
<https://doi.org/10.1111/j.1365-2141.2005.05757.x>
